China approves inactivated COVID-19 vaccines for clinical trials - Plataforma Media

China approves inactivated COVID-19 vaccines for clinical trials

The two vaccine candidates are developed by Wuhan Institute of Biological Products under the China National Pharmaceutical Group (Sinopharm) and Sinovac Research and Development Co., Ltd, a company based in Beijing. Clinical trials of the two vaccines have started.

Related posts
SocietyWorld

Boris Johnson and António Guterres discuss increased vaccine production

SocietyWorld

New cases of covid-19 decreased 16% last week

BrazilSociety

Clandestine parties gather more than 10,000 people in São Paulo

SocietyWorld

North Korea tried to hack Pfizer systems

Subscribe to our Newsletter.